Evidence map›Paper›PMID 29368659›Full record

ArticleParasites & vectors2018

Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.

Santiago Radio, Santiago Fontenla, Victoria Solana, Anna C Matos Salim, Flávio Marcos Gomes Araújo, Pedro Ortiz, Cristian Hoban, Estefan Miranda, Valeria Gayo, Fabiano Sviatopolk-Mirsky Pais and 4 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Triclabendazole and Other Fasciolicides: Resistance ofAnimals : an open access journal from MDPI · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Drug resistance in liver flukes.International journal for parasitology. Drugs and drug resistance · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 5 countries.

Santiago RadioDepartamento de Genética, Facultad de Medicina, Universidad de la Republica, UDELAR, Montevideo, Uruguay.
Santiago FontenlaDepartamento de Genética, Facultad de Medicina, Universidad de la Republica, UDELAR, Montevideo, Uruguay.
Victoria SolanaLaboratorio de Biología Celular y Molecular, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina.
Anna C Matos SalimCentro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Flávio Marcos Gomes AraújoCentro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Pedro OrtizLaboratorio de Inmunología, Facultad de Ciencias Veterinarias, Universidad Nacional de Cajamarca, Cajamarca, Peru.
Cristian HobanLaboratorio de Inmunología, Facultad de Ciencias Veterinarias, Universidad Nacional de Cajamarca, Cajamarca, Peru.
Estefan MirandaInstituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias, Secretaria de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación, Morelos, Mexico.
Valeria GayoDepartamento de Parasitología, División de Laboratorios Veterinarios (DILAVE), "Miguel C. Rubino", Ministerio de Ganadería, Agricultura y Pesca (MGAP), Montevideo, Uruguay.
Fabiano Sviatopolk-Mirsky PaisCentro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Hugo SolanaLaboratorio de Biología Celular y Molecular, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina.
Guilherme OliveiraCentro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Pablo SmircichDepartamento de Genética, Facultad de Medicina, Universidad de la Republica, UDELAR, Montevideo, Uruguay. psmircich@fmed.edu.uy.
José F TortDepartamento de Genética, Facultad de Medicina, Universidad de la Republica, UDELAR, Montevideo, Uruguay. jtort@fmed.edu.uy.
Fundação Oswaldo Cruz · BRUniversidad de la República · UYNational University of Cajamarca · PEUniversidad Nacional del Centro de la Provincia de Buenos Aires · ARInstituto Nacional de Investigaciones Forestales Agrícolas y Pecuarias · MXMinisterio de Ganadería Agricultura y Pesca · UY

Funding

Centro Argentino Brasilerno de Biotecnologia (CABBIO) 2012/04
6 · The paper itself

Abstract

backgroundFasciola hepatica is the main agent of fasciolosis, a zoonotic disease affecting livestock worldwide, and an emerging food-borne disease in humans. Even when effective treatments are available, drugs are costly and can result in tolerance, liver damage and normally they do not prevent reinfection. Drug-resistant strains in livestock have been reported in various countries and, more worryingly, drug resistance in human cases has emerged in South America. The present study aims to characterize the transcriptome of two South American resistant isolates, the Cajamarca isolate from Peru, resistant to both triclabendazole and albendazole (TCBZR/ABZR) and the Rubino isolate from Uruguay, resistant to ABZ (TCBZS/ABZR), and compare them to a sensitive strain (Cenapa, Mexico, TCBZS/ABZS) to reveal putative molecular mechanisms leading to drug resistance.

resultsWe observed a major reduction in transcription in the Cajamarca TCBZR/ABZR isolate in comparison to the other isolates. While most of the differentially expressed genes are still unannotated, several trends could be detected. Specific reduction in the expression levels of cytoskeleton proteins was consistent with a role of tubulins as putative targets of triclabendazole (TCBZ). A marked reduction of adenylate cyclase might be underlying pleiotropic effects on diverse metabolic pathways of the parasite. Upregulation of GST mu isoforms suggests this detoxifying mechanism as one of the strategies associated with resistance.

conclusionsOur results stress the value of transcriptomic approaches as a means of providing novel insights to advance the understanding of drug mode of action and drug resistance. The results provide evidence for pleiotropic variations in drug-resistant isolates consistent with early observations of TCBZ and ABZ effects and recent proteomic findings.

Indexed as

Gene ExpressionAlbendazoleAnimalsAnthelminticsDrug Resistance, MultipleFasciola hepaticaFascioliasisGene Expression ProfilingHumansMexicoPeruProteomicsSouth AmericaTriclabendazoleUruguayAlbendazoleAnthelminticsTriclabendazoleAlbendazoleAmerican isolatesDrug resistanceFascola hepaticaTranscriptomicsTriclabendazole

Identifiers

PMID29368659
PMCPMC5781333
OpenAlexW2797684339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.